Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-89,650
Closed -$7.1M 45
2020
Q3
$7.1M Sell
89,650
-8,798
-9% -$689K 0.37% 43
2020
Q2
$7.26M Sell
98,448
-49,611
-34% -$3.73M 0.45% 44
2020
Q1
$10.9M Hold
148,059
0.76% 27
2019
Q4
$13M Sell
148,059
-100,572
-40% -$8.26M 0.72% 28
2019
Q3
$20M Buy
248,631
+19,125
+8% +$1.53M 1.28% 24
2019
Q2
$18.4M Buy
229,506
+40
+0% +$3.06K 1.31% 20
2019
Q1
$18.2M Sell
229,466
-158,911
-41% -$11.9M 1.28% 21
2018
Q4
$28.3M Buy
388,377
+67,459
+21% +$4.76M 2.3% 9
2018
Q3
$21.7M Buy
320,918
+78,075
+32% +$4.97M 1.51% 17
2018
Q2
$14.1M Buy
242,843
+332
+0.1% +$18.7K 0.98% 23
2018
Q1
$12.6M Buy
242,511
+1,551
+0.6% +$83.8K 0.87% 25
2017
Q4
$12.9M Buy
240,960
+40,687
+20% +$2.26M 0.91% 25
2017
Q3
$12.2M Buy
200,273
+5,240
+3% +$318K 0.94% 33
2017
Q2
$11.9M Hold
195,033
0.96% 32
2017
Q1
$11.8M Sell
195,033
-25,466
-12% -$1.55M 0.98% 36
2016
Q4
$12.4M Sell
220,499
-105
-0% -$6.14K 1.16% 31
2016
Q3
$13.1M Hold
220,604
1.19% 30
2016
Q2
$12.1M Buy
220,604
+13,729
+7% +$731K 1.17% 32
2016
Q1
$10.4M Sell
206,875
-1,572
-0.8% -$77K 1% 37
2015
Q4
$10.5M Hold
208,447
1.06% 38
2015
Q3
$9.82M Sell
208,447
-419
-0.2% -$22.3K 1.02% 37
2015
Q2
$11.3M Buy
208,866
+17,920
+9% +$1.01M 1.08% 34
2015
Q1
$10.5M Buy
+190,946
New +$10.8M 0.94% 39

Other funds holding MRK

Martin Currie's MRK Position: Q4 2020 in Review

Martin Currie sold out of Merck (MRK) in Q4 2020, closing a stake of 89,650 shares — an estimated $7.1M sold.

Martin Currie first reported a position in MRK in Q1 2015 and held it in 23 quarters. The position peaked at $28.3M in Q4 2018. 2,709 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Martin Currie reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Martin Currie sold 89,650 Merck shares in Q4 2020, an estimated $7.1M.
  • Martin Currie first reported a position in Merck in Q1 2015 and held it in 23 quarters.
  • Martin Currie's Merck position peaked at $28.3M in Q4 2018.
  • 2,709 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Martin Currie's 13F filing for Q4 2020, filed 10 Feb 2021.